BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 10294730)

  • 1. "We're not ostriches anymore!".
    Schutte JE
    Med Econ; 1989 Sep; 66(18):131, 135-6, 139. PubMed ID: 10294730
    [No Abstract]   [Full Text] [Related]  

  • 2. The AMA's big loss in Congress.
    New Physician; 1983; 32(1):27-8. PubMed ID: 10258416
    [No Abstract]   [Full Text] [Related]  

  • 3. The growing battle over doctors selling drugs.
    Cassidy R
    Med Econ; 1988 May; 65(10):66-9, 72, 79 passim. PubMed ID: 10287484
    [No Abstract]   [Full Text] [Related]  

  • 4. Should the FTC regulate American medicine?
    Rial W
    Natl J (Wash); 1982 Sep; 14(37):1576-7. PubMed ID: 10256460
    [No Abstract]   [Full Text] [Related]  

  • 5. Lawmakers concur with ACP on key aspects of debate.
    Am Coll Physicians Obs; 1983; 3(7):3. PubMed ID: 10263084
    [No Abstract]   [Full Text] [Related]  

  • 6. Why five soloists are suing a big group.
    Holoweiko M
    Med Econ; 1982 Jun; 59(13):74-8, 79. PubMed ID: 10255677
    [No Abstract]   [Full Text] [Related]  

  • 7. Wilk v. American Medical Association--AMA enjoined from advocating boycott of chiropractors; individual choice endorsed.
    Cohen HH
    Med Staff Couns; 1988; 2(2):63-9. PubMed ID: 10286483
    [No Abstract]   [Full Text] [Related]  

  • 8. U.S. Supreme Court rejects case-by-case antitrust analysis in Maricopa.
    McCann RW
    Health Law Vigil; 1982 Jun; 5(13):1-4. PubMed ID: 10256005
    [No Abstract]   [Full Text] [Related]  

  • 9. Antitrust implications for health planning.
    Davis CD
    Tex Hosp; 1984 May; 39(12):59, 61-2. PubMed ID: 10266793
    [No Abstract]   [Full Text] [Related]  

  • 10. Competition among physicians. Avoiding anticompetitive activities.
    Oliver D
    Consultant; 1988 Dec; 28(12):60-1, 68, 73. PubMed ID: 10290553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. District court denies summary judgment on physician's antitrust claim.
    Urbanski MF
    Health Law Vigil; 1988 Oct; 11(21):5-6. PubMed ID: 10288891
    [No Abstract]   [Full Text] [Related]  

  • 12. Arizona v. Maricopa County: a stern antitrust warning to healthcare providers.
    Halper HR
    Healthc Financ Manage; 1982 Oct; 36(10):38-42. PubMed ID: 10315212
    [No Abstract]   [Full Text] [Related]  

  • 13. Hospital competition and antitrust: the Federal Trade Commission staff report.
    Miles JJ
    Health Law Vigil; 1987 Jul; 10(14):6-10. PubMed ID: 10282648
    [No Abstract]   [Full Text] [Related]  

  • 14. Market definition, market power, and potential competition.
    Horowitz I
    Q Rev Econ Bus; 1982; 22(3):23-42. PubMed ID: 10257262
    [No Abstract]   [Full Text] [Related]  

  • 15. Steering clear of an antitrust charge.
    Trombetta WL
    Med Econ; 1986 Aug; 63(16):105-9, 112. PubMed ID: 10277667
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of quality of health care considerations in antitrust analysis.
    Kauper TE
    Law Contemp Probl; 1988; 51(2):273-340. PubMed ID: 10296906
    [No Abstract]   [Full Text] [Related]  

  • 17. Perspectives. Wakened FTC worries providers.
    Mcgraw Hills Med Health; 1988 Apr; 42(14):suppl 4 p.. PubMed ID: 10286492
    [No Abstract]   [Full Text] [Related]  

  • 18. Maricopa aftermath: what is required for a physician group to achieve integration?
    Stromberg RE; Goldman JS
    Health Law Vigil; 1985 Jan; 8(1):17-20. PubMed ID: 10269416
    [No Abstract]   [Full Text] [Related]  

  • 19. Exclusive contracts and hospital privileges--the physician's perspective.
    Chenen AR
    Med Staff Couns; 1988; 2(1):35-40. PubMed ID: 10285826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient care not enough as defense for provider conduct.
    Hammaker MK
    Provider; 1987 Dec; 13(12):30-1, 40. PubMed ID: 10285093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.